B
이지바이오
353810KOSDAQ63.0 / 100
Reference Date: 2026-10-23
Financial Score32.5 / 40
News Sentiment12.5 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: PER is significantly undervalued vs. peers and ROE significantly exceeds the industry average is also solid. Declined 10.2% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
EASY BIO primarily operates in the production and sale of piglet feed and feed additives, with subsidiaries such as Devenish Nutrition and Pathway Intermediates. The piglet feed market is gaining significance due to the growth of the pork industry, while feed additives are evolving as high-value-added business segments aligned with eco-friendly and antibiotic-free trends.
Number of Employees
143people
Average Salary
62.8M KRW
Score Calculation Basis
Detailed Financial Score
PER
6.60Industry Average 15.008.0Point
Half of industry avg (excellent)
PBR
1.61Industry Average 1.202.5Point
Higher than industry avg (caution)
ROE
28.93Industry Average 8.007.0Point
3.6x industry avg (excellent)
Debt Ratio
65.22Industry Average 100.005.0Point
Lower than industry avg (good)
Trend 2023~202510.0 / 10 points
Revenue Growth Rate
3.0 / 3
Avg ▲78.2% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲47.9% (2-year basis)
ROE Trend
4.0 / 4
Avg ROE 27.2% (improving, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (5%, downtrend)
Current 5,540Won52-week high 8,06052-week low 5,380
1-month return1.0Point
1m -10.21% (falling)
Volume trend6.0Point
Volume increasing
Detailed Disclosure
1 totalPositive 0Neutral 1Negative 0
- Neutral주식등의대량보유상황보고서(약식)2026-10-19